ICU Medical Inc
XBER:IC7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
ICU Medical Inc
XBER:IC7
|
US |
|
R
|
Raphael Pharmaceutical Inc
OTC:RAPH
|
US |
|
C
|
Clydesdale Resources Inc
XTSX:CEO.H
|
CA |
|
P
|
Propel Funeral Partners Ltd
OTC:PFPLF
|
AU |
Wall St Price Targets
IC7 Price Targets Summary
ICU Medical Inc
According to Wall Street analysts, the average 1-year price target for
IC7 is 119.16 EUR with a low forecast of 109.01 EUR and a high forecast of 139.06 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IC7's stock price target?
Price Target
119.16
EUR
According to Wall Street analysts, the average 1-year price target for
IC7 is 119.16 EUR with a low forecast of 109.01 EUR and a high forecast of 139.06 EUR.
What is the Revenue forecast for ICU Medical Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 5 years is 5%.
What is the Gross Profit forecast for ICU Medical Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 5 years is 8%.
What is the Operating Income forecast for ICU Medical Inc?
Projected CAGR
56%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 56%.
What is the Pre-Tax Income forecast for ICU Medical Inc?
Projected CAGR
330%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -18%. The projected CAGR for the next 3 years is 330%.
What is the Net Income forecast for ICU Medical Inc?
Projected CAGR
240%
Over the last 13 years, the compound annual growth rate for Net Income has been -27%. The projected CAGR for the next 5 years is 240%.